• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: EPILEPSY

REPORT FROM EAN 2024 – TUESDAY, JULY 2, 2024

July 2, 2024  

New developments in epilepsy: focus on cenobamate

May 2, 2024  

REPORT FROM AAN 2024 – THURSDAY, APRIL 18

April 18, 2024  

REPORT FROM AAN 2024 – WEDNESDAY, APRIL 17

April 17, 2024  

REPORT FROM AAN 2024 – TUESDAY, APRIL 16

April 16, 2024  

Elevated sNfL a possible biomarker of recent seizure in epilepsy

April 5, 2024  

CNS effects of Wegovy (semaglutide)

February 28, 2023  

Phase III trials in neurology – 2018 in review

January 24, 2019  

Record number of FDA drug approvals in 2018

January 9, 2019  

Marijuana in neurology – POTential benefit?

March 23, 2018  
1
2
3
4

Browse by Topic

  • MS (441)
  • EAN 2026 (2)
  • CLINICAL CASES (21)
  • AAN 2026 (3)
  • ACTRIMS Forum 2026 (4)
  • AES 2025 (1)
  • EPILEPSY (38)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Highlights of EAN 2026 – Part 2 posted on July 9, 2026
  • Highlights of EAN 2026 – Part 1 posted on June 30, 2026
  • CLINICAL CASES IN NEUROLOGY – A PERIMENOPAUSAL WOMAN WITH MIGRAINE AND HEAD TRAUMA posted on May 25, 2026
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions